BACKGROUND: The MATRICS Consensus Cognitive Battery (MCCB) and proposed co-primary measures are gaining momentum as outcome measures in clinical trials, highlighting the need to evaluate their psychometric properties. The MCCB composite score has been proposed to be the optimal primary outcome measure, though its validity is unknown. This study aimed to evaluate the factor structure of the MCCB in a schizophrenia sample and determine whether its cognitive domains are separable. METHODS: 183 outpatients with schizophrenia or schizoaffective disorder completed a comprehensive test battery. Confirmatory factor analysis was used to test the factor structure of the MCCB; hierarchical regression then examined the relative contribution of individual cognitive variables to predict the MCCB factor scores. Finally, the relationships between the resulting factors and two performance-based measures of functional capacity were explored. RESULTS: A three-factor MCCB model representing processing speed, attention/working memory, and learning fits the data well and was an improvement over a unifactorial model. Symbol coding, spatial span, and visual learning were the most robust predictors for each of the three factors; symbol coding proved to be the best single predictor of overall cognitive performance. The three factors were also significantly related to a performance-based measure of everyday functioning but not a performance-based measure of social skills. CONCLUSIONS: These analyses suggest that the six MCCB "domains" as constructed can be collapsed into fewer domains composed of multiple item scores; they also support the notion that impaired processing speed is a fundamental cognitive deficit in schizophrenia and that MCCB performance is related to functional capacity. Cognition and functional capacity measures require more research to determine if they differ. Published by Elsevier B.V.
BACKGROUND: The MATRICS Consensus Cognitive Battery (MCCB) and proposed co-primary measures are gaining momentum as outcome measures in clinical trials, highlighting the need to evaluate their psychometric properties. The MCCB composite score has been proposed to be the optimal primary outcome measure, though its validity is unknown. This study aimed to evaluate the factor structure of the MCCB in a schizophrenia sample and determine whether its cognitive domains are separable. METHODS: 183 outpatients with schizophrenia or schizoaffective disorder completed a comprehensive test battery. Confirmatory factor analysis was used to test the factor structure of the MCCB; hierarchical regression then examined the relative contribution of individual cognitive variables to predict the MCCB factor scores. Finally, the relationships between the resulting factors and two performance-based measures of functional capacity were explored. RESULTS: A three-factor MCCB model representing processing speed, attention/working memory, and learning fits the data well and was an improvement over a unifactorial model. Symbol coding, spatial span, and visual learning were the most robust predictors for each of the three factors; symbol coding proved to be the best single predictor of overall cognitive performance. The three factors were also significantly related to a performance-based measure of everyday functioning but not a performance-based measure of social skills. CONCLUSIONS: These analyses suggest that the six MCCB "domains" as constructed can be collapsed into fewer domains composed of multiple item scores; they also support the notion that impaired processing speed is a fundamental cognitive deficit in schizophrenia and that MCCB performance is related to functional capacity. Cognition and functional capacity measures require more research to determine if they differ. Published by Elsevier B.V.
Authors: Michael F Green; Keith H Nuechterlein; Robert S Kern; Lyle E Baade; Wayne S Fenton; James M Gold; Richard S E Keefe; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Stephen R Marder Journal: Am J Psychiatry Date: 2008-01-02 Impact factor: 18.112
Authors: Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder Journal: Am J Psychiatry Date: 2008-01-02 Impact factor: 18.112
Authors: Richard S E Keefe; Robert M Bilder; Philip D Harvey; Sonia M Davis; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; Del D Miller; Jose M Canive; Lawrence W Adler; Theo C Manschreck; Marvin Swartz; Robert Rosenheck; Diana O Perkins; Trina M Walker; T Scott Stroup; Joseph P McEvoy; Jeffrey A Lieberman Journal: Neuropsychopharmacology Date: 2006-04-19 Impact factor: 7.853
Authors: Christopher R Bowie; Abraham Reichenberg; Thomas L Patterson; Robert K Heaton; Philip D Harvey Journal: Am J Psychiatry Date: 2006-03 Impact factor: 18.112
Authors: Philip D Harvey; Lars Helldin; Christopher R Bowie; Robert K Heaton; Anna-Karin Olsson; Fredrik Hjärthag; Torsten Norlander; Thomas L Patterson Journal: Am J Psychiatry Date: 2009-06-01 Impact factor: 18.112
Authors: Brent T Mausbach; Phillip D Harvey; Sherry R Goldman; Dilip V Jeste; Thomas L Patterson Journal: Schizophr Bull Date: 2007-03-06 Impact factor: 9.306
Authors: Lea Vella; Thomas L Patterson; Philip D Harvey; Margaret McNamara McClure; Brent T Mausbach; Michael J Taylor; Elizabeth W Twamley Journal: Psychiatry Res Date: 2017-06-12 Impact factor: 3.222
Authors: Richard S E Keefe; Vicki G Davis; Nathan B Spagnola; Dana Hilt; Nancy Dgetluck; Stacy Ruse; Thomas D Patterson; Meera Narasimhan; Philip D Harvey Journal: Eur Neuropsychopharmacol Date: 2014-06-28 Impact factor: 4.600
Authors: William S Stone; Raquelle I Mesholam-Gately; Anthony J Giuliano; Kristen A Woodberry; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert W McCarley; Robert Heinssen; Michael F Green; Keith Nuechterlein; Larry J Seidman Journal: Schizophr Res Date: 2016-02-16 Impact factor: 4.939
Authors: Jing Sui; Godfrey D Pearlson; Yuhui Du; Qingbao Yu; Thomas R Jones; Jiayu Chen; Tianzi Jiang; Juan Bustillo; Vince D Calhoun Journal: Biol Psychiatry Date: 2015-02-24 Impact factor: 13.382
Authors: Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman Journal: Am J Psychiatry Date: 2014-05 Impact factor: 18.112
Authors: A McCleery; M F Green; G S Hellemann; L E Baade; J M Gold; R S E Keefe; R S Kern; R I Mesholam-Gately; L J Seidman; K L Subotnik; J Ventura; K H Nuechterlein Journal: Psychol Med Date: 2015-04-28 Impact factor: 7.723
Authors: Lindsay D Oliver; John D Haltigan; James M Gold; George Foussias; Pamela DeRosse; Robert W Buchanan; Anil K Malhotra; Aristotle N Voineskos Journal: Schizophr Bull Date: 2019-04-25 Impact factor: 9.306